|
112
|
400
|
6vuuA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt1347 |
|
106
|
400
|
6vuyA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt358 |
|
106
|
400
|
6vutA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt392 |
|
90
|
297
|
6vqlA |
Crystal structure of interleukin-1 receptor-associated kinase 4 (irak4-wt) complex with a nicotinamide inhibitor |
|
108
|
400
|
6vv3A |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt1358 |
|
112
|
400
|
6vurA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt366 |
|
112
|
400
|
6vusA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt379 |
|
110
|
400
|
6vuzA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt353 |
|
111
|
400
|
6vv2A |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt1348 |
|
115
|
400
|
6vuxA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt388 |
|
105
|
400
|
6vv0A |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt1354 |
|
51
|
154
|
6vlmA |
Core catalytic domain of hiv integrase in complex with virtual screening hit |
|
39
|
155
|
6u9nA |
Mll1 set n3861i/q3867l bound to inhibitor 14 (tc-5139) |
|
35
|
156
|
6u9kA |
Mll1 set n3861i/q3867l bound to inhibitor 18 (tc-5153) |
|
39
|
155
|
6u9mA |
Mll1 set n3861i/q3867l bound to inhibitor 16 (tc-5109) |
|
41
|
156
|
6u9rA |
Mll1 set n3861i/q3867l bound to inhibitor 12 (tc-5140) |
|
109
|
339
|
6q2aA |
Trypanosoma brucei clk1 kinase domain in complex with a covalent aminobenzimidazole inhibitor ab1 |
|
100
|
265
|
6w9hA |
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t agonists |
|
100
|
265
|
6w9jA |
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t agonists |
|
97
|
330
|
6w6dA |
Crystal structure of human protein arginine n-methyltransferase 6 (prmt6) in complex with sgc6870 inhibitor |
|
98
|
265
|
6w9iA |
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t agonists |
|
93
|
307
|
6v6oA |
Egfr(t790m/v948r) in complex with ln2380 |
|
92
|
315
|
6v6kA |
Egfr(t790m/v948r) in complex with ln2057 |
|
97
|
314
|
6v5nA |
Egfr(t790m/v948r) in complex with ln2084 |
|
86
|
324
|
6vh4A |
Wild type egfr in complex with ln2380 |
|
85
|
324
|
6vhpA |
Wild type egfr in complex with ln2899 |
|
88
|
324
|
6vhnA |
Wild type egfr in complex with ln2057 |
|
96
|
314
|
6v5pA |
Egfr(t790m/v948r) in complex with ln2725 |
|
96
|
314
|
6v66A |
Egfr(t790m/v948r) in complex with ln2899 |
|
84
|
279
|
6ol2A |
Crystallography of novel wnk1 and wnk3 inhibitors discovered from high-throughput-screening |
|
80
|
272
|
6pdaA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 74 |
|
80
|
272
|
6pdbA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 80 |
|
79
|
272
|
6pdeA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 40 |
|
78
|
272
|
6pdfA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 55 |
|
84
|
272
|
6pdgA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 83 |
|
46
|
162
|
6kroA |
Tankyrase-2 in complex with rk-582 |
|
75
|
272
|
6pd8A |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 39 |
|
71
|
272
|
6pd9A |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 60 |
|
1
|
46
|
6kroB |
Tankyrase-2 in complex with rk-582 |
|
79
|
272
|
6owhA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 92 |
|
84
|
272
|
6pdcA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 42 |
|
83
|
272
|
6pddA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 41 |
|
87
|
290
|
6v9cA |
Crystal structure of fgfr4 kinase domain in complex with covalent inhibitor |
|
84
|
272
|
6oblA |
Jak2 jh2 in complex with jak168 |
|
86
|
272
|
6obfA |
Jak2 jh2 in complex with jak179 |
|
85
|
272
|
6obbA |
Jak2 jh2 in complex with jak170 |
|
86
|
272
|
6oavA |
Jak2 jh2 in complex with jak146 |
|
83
|
272
|
6occA |
Jak2 jh2 in complex with jak190 |
|
98
|
322
|
6vzhA |
Structure of human vaccinia-related kinase 1 (vrk1) bound to ldsm311 |
|
88
|
306
|
6vhgA |
Crystal structure of phosphorylated ret tyrosine kinase domain complexed with a pyrazolo[1,5-a]pyrimidine inhibitor |
